Genedata Releases Electronic Lab Notebook System for Biopharmaceutical Research
Genedata has launched a new integrated electronic lab notebook designed to manage experimental data and facilitate AI-readiness in biopharmaceutical R&D workflows.
Genedata, a subsidiary of Danaher, has released a new electronic lab notebook (ELN) aimed at streamlining data management within biopharmaceutical research and development departments. The software is designed to integrate experimental context with structured scientific data across established research workflows.
The system addresses a common challenge in the life sciences sector: the fragmentation of data. By centralizing information, the platform aims to provide a foundation for data analysis and machine learning applications. In the context of pharmaceutical development, this type of integration is intended to reduce the time required for data processing and collaborative decision-making.
The release comes as biopharma companies increasingly prioritize digital infrastructure to shorten drug discovery cycles. By automating the capture of experimental data, the software aims to minimize manual transcription errors and improve the traceability of research results.
This launch marks a step in Genedata’s ongoing strategy to provide standardized software tools for R&D automation. The company continues to focus on developing enterprise-level digital platforms for high-throughput screening and complex biological research environments.